According to the latest report published by Credence Research, Inc. “Global Pharmacovigilance Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the pharmacovigilance market was valued at USD 2,159.3 Mn in 2015, and is expected to reach USD 5,896.4 Mn by 2022, expanding at a CAGR of 15.8% from 2016 to 2022.
According to the latest report published by Credence Research, Inc. “Global Pharmacovigilance Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the pharmacovigilance market was valued at USD 2,159.3 Mn in 2015, and is expected to reach USD 5,896.4 Mn by 2022, expanding at a CAGR of 15.8% from 2016 to 2022.
Pharmacovigilance is a critical component of healthcare systems worldwide, aiming to ensure the safety and efficacy of medications. As the field continues to evolve, it becomes increasingly important to establish and implement pharmacovigilance best practices. These practices serve as guidelines for building a robust pharmacovigilance system that effectively identifies, monitors, and manages adverse drug reactions (ADRs) and other drug-related issues.
Pharmacovigilance refers to the monitoring of approved drugs and vaccines to detect adverse drug reactions and identify safety hazards. It encompasses the collection and interpretation of data from all relevant sources and the prompt communication of new safety information to health authorities, health care providers and patients. The rising burden of chronic diseases and increasing consumption of prescription medicines have fueled the need for effective pharmacovigilance measures across the ... Read more
